Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations

被引:16
|
作者
Cocherie, Theophile [1 ]
Zafilaza, Karen [1 ]
Leducq, Valentin [1 ]
Marot, Stephane [1 ]
Calvez, Vincent [1 ]
Marcelin, Anne-Genevieve [1 ]
Todesco, Eve [1 ]
机构
[1] Sorbonne Univ, Hop Pitie Salpetriere, Assistance Publ Hop Paris AP HP, Inst Pierre Louis Epidemiol & St Publ iPLESP,INSER, F-75013 Paris, France
关键词
SARS-CoV-2; COVID-19; Spike glycoprotein; immune evasion; transmissibility; variants; variants of concern; EMERGENCE; IMMUNITY; PROTEIN; L452R;
D O I
10.3390/microorganisms11010030
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
SARS-CoV-2 expresses on its surface the Spike protein responsible for binding with the ACE2 receptor and which carries the majority of immunodominant epitopes. Mutations mainly affect this protein and can modify characteristics of the virus, giving each variant a unique profile concerning its transmissibility, virulence, and immune escape. The first lineage selected is the B.1 lineage characterized by the D614G substitution and from which all SARS-CoV-2 variants of concern have emerged. The first three variants of concern Alpha, Beta, and Gamma spread in early 2021: all shared the N501Y substitution. These variants were replaced by the Delta variant in summer 2021, carrying unique mutations like the L452R substitution and associated with higher virulence. It was in turn quickly replaced by the Omicron variant at the end of 2021, which has predominated since then, characterized by its large number of mutations. The successive appearance of variants of concern showed a dynamic evolution of SARS-CoV-2 through the selection and accumulation of mutations. This has not only allowed progressive improvement of the transmissibility of SARS-CoV-2, but has also participated in a better immune escape of the virus. This review brings together acquired knowledge about SARS-CoV-2 variants of concern and the impacts of the Spike mutations.
引用
收藏
页数:13
相关论文
共 50 条
  • [11] SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
    Ji Yun Noh
    Hye Won Jeong
    Eui-Cheol Shin
    [J]. Signal Transduction and Targeted Therapy, 6
  • [12] SARS-CoV-2 mutations, vaccines, and immunity: implication of variants of concern
    Noh, Ji Yun
    Jeong, Hye Won
    Shin, Eui-Cheol
    [J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [13] Molecular Level Dissection of Critical Spike Mutations in SARS-CoV-2 Variants of Concern (VOCs): A Simplified Review
    Joshi, Nilesh
    Tyagi, Adish
    Nigam, Sandeep
    [J]. CHEMISTRYSELECT, 2021, 6 (31): : 7981 - 7998
  • [14] The SARS-CoV-2 Variants and their Impacts
    Shukri, Amir Muhaimin Akmal
    Wang, Seok Mui
    Chia, Suet Lin
    Nawi, Siti Farah Alwani Mohd
    [J]. JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (03): : 1409 - 1424
  • [15] The emerging SARS-CoV-2 variants of concern
    Sanyaolu, Adekunle
    Okorie, Chuku
    Marinkovic, Aleksandra
    Haider, Nafees
    Abbasi, Abu Fahad
    Jaferi, Urooj
    Prakash, Stephanie
    Balendra, Vyshnavy
    [J]. THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE, 2021, 8
  • [16] SARS-CoV-2 variants of concern: a review
    Sarkar, Malay
    Madabhavi, Irappa
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2023, 93 (03)
  • [17] The origin of SARS-CoV-2 variants of concern
    Burki, Talha
    [J]. LANCET INFECTIOUS DISEASES, 2022, 22 (02): : 174 - 175
  • [18] Immunity to SARS-CoV-2 variants of concern
    Altmann, Daniel M.
    Boyton, Rosemary J.
    Beale, Rupert
    [J]. SCIENCE, 2021, 371 (6534) : 1103 - 1104
  • [19] SARS-CoV-2 spike gene Sanger sequencing methodology to identify variants of concern
    Alhamlan, Fatimah S.
    Bakheet, Dana M.
    Bohol, Marie F.
    Alsanea, Madain S.
    Alahideb, Basma M.
    Alhadeq, Faten M.
    Alsuwairi, Feda A.
    Al-Abdulkareem, Maha A.
    Asiri, Mohamed S.
    Almaghrabi, Reem S.
    Altamimi, Sarah A.
    Mutabagani, Maysoon S.
    Althawadi, Sahar, I
    Al-Qahtani, Ahmed A.
    [J]. BIOTECHNIQUES, 2023, 74 (02) : 69 - 75
  • [20] A third SARS-CoV-2 spike vaccination improves neutralization of variants-of-concern
    Mitch Brinkkemper
    Philip J. M. Brouwer
    Pauline Maisonnasse
    Marloes Grobben
    Tom G. Caniels
    Meliawati Poniman
    Judith A. Burger
    Ilja Bontjer
    Melissa Oomen
    Joey H. Bouhuijs
    Cynthia A. van der Linden
    Julien Villaudy
    Yme U. van der Velden
    Kwinten Sliepen
    Marit J. van Gils
    Roger Le Grand
    Rogier W. Sanders
    [J]. npj Vaccines, 6